𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension

✍ Scribed by Agustín Albillos*; Juan–Carlos García–Pagán‡; Jerónimo Iborra*; Juan–Carlos Bandi‡; Guillermo Cacho*; María Pérez–Paramo§; Angels Escorsell‡; José Luis Calleja*; Pedro Escartín*; Jaime Bosch‡


Book ID
118520325
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
155 KB
Volume
115
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Propranolol plus isosorbide-5-mononitrat
✍ Rosa Maria Morillas; Ramon Planas; Eduard Cabré; Amparo Galán; Juan Carlos Quer; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

The effect on kidney function, vasoactive systems and ascites outcome of long-term treatment with propranolol plus isosorbide-5-mononitrate, a combined therapy proven more effective than propranolol alone in decreasing portal pressure in the cirrhotic patient, is unknown. Thirty cirrhotic patients w

Propranolol compared with propranolol pl
✍ Julio Vorobioff; Eduardo Picabea; Marcelo Gamen; Roberto Villavicencio; Juan Bor 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 844 KB

The long-term hemodynamic and renal effects of propranolol were compared with those of propranolol plus isosorbide dinitrate in 44 portal-hypertensive alcoholic cirrhotic patients. Eight control patients, 8 patients receiving propranolol and 14 patients receiving propranolol plus isosorbide dinitrat

Enhancement of portal pressure reduction
✍ Joan Carles Garcia-Pagan; Miquel Navasa; Jaime Bosch; Conxita Bru; Pilar Pizcuet 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 879 KB

This study investigated whether oral doses of isosorbide-5-mononitrate, a preferential venous dilator that decreases portal pressure, could enhance the effects of propranolol on portal hypertension. Taking part in the study were 28 patients with cirrhosis and portal hypertension. Twenty patients (gr